"Naproxen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.
| Descriptor ID |
D009288
|
| MeSH Number(s) |
D02.455.426.559.847.638.472.500 D04.615.638.472.450
|
| Concept/Terms |
Naproxen Sodium- Naproxen Sodium
- Sodium, Naproxen
- Sodium Naproxenate
- Naproxenate, Sodium
|
Below are MeSH descriptors whose meaning is more general than "Naproxen".
Below are MeSH descriptors whose meaning is more specific than "Naproxen".
This graph shows the total number of publications written about "Naproxen" by people in this website by year, and whether "Naproxen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 2 | 4 |
| 2020 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Naproxen" by people in Profiles.
-
Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa. Front Immunol. 2023; 14:1162669.
-
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. Gut. 2021 03; 70(3):555-566.
-
Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial. Am J Gastroenterol. 2018 07; 113(7):1053-1054.
-
Editorial: gastrointestinal safety of COX-2 selective and nonselective NSAIDs-the impact of the PRECISION trial. Authors' reply. Aliment Pharmacol Ther. 2018 06; 47(11):1546-1547.
-
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Aliment Pharmacol Ther. 2018 06; 47(11):1453-1463.
-
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial. Arthritis Rheumatol. 2018 04; 70(4):537-546.
-
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. Eur Heart J. 2017 Nov 21; 38(44):3282-3292.
-
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial. Am J Med. 2017 12; 130(12):1415-1422.e4.
-
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med. 2016 12 29; 375(26):2519-29.
-
Removal of pain-relieving drugs from aqueous solutions using Octolig and selected metalloligs. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2015; 50(8):788-93.